Skip to content

Clinical trials

Neoplasm Metastasis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Canada Clear all

324 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20025
20037
200413
20056
20067
20077
200815
200915
201012
201113
201212
201316
201414
201513
201616
201714
201812
201915
202021
202113
202218
202310
20249
202519
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed156
Active, not recruiting54
Terminated50
Recruiting43
Unknown status11
Not yet recruiting6
Withdrawn3
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto27
AstraZeneca24
Novartis Pharmaceuticals13
Eli Lilly and Company12
British Columbia Cancer Agency11
Pfizer11
Bristol-Myers Squibb8
Radiation Therapy Oncology Group8
National Cancer Institute (NCI)7
Sanofi7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis324
Neoplasms63
Breast Neoplasms61
Carcinoma, Non-Small-Cell Lung35
Colorectal Neoplasms34
Melanoma23
Prostatic Neoplasms23
Brain Neoplasms18
Carcinoma, Renal Cell18
Recurrence18

Trials

Showing 1 to 25 of 324. Each trial links to its page on Pharma Observatory.

224 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.